Back to search results

Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma

Abroad (travel likely)RecruitingPHASE2

Conditions

Neuroblastoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota, United States

    Contact: Study coordinator (Lisa Burke, RN) · lburke3@Fairview.org · 612-273-8482
    Contact: Principal Investigator (Ashish Gupta, MBBS, MPH)
Study leads

  • Ashish Gupta, MBBS, MPH

    Principal Investigator

    Masonic Cancer Center, University of Minnesota

View source on ClinicalTrials.gov(opens in a new tab)